Use of tocilizumab in a patient with pyoderma gangrenosum and rheumatoid arthritis-Reference-Cited by-同舟云学术

Use of tocilizumab in a patient with pyoderma gangrenosum and rheumatoid arthritis

Published:2016-06-21 Issue:2 Volume:31 Page:e75-e77
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Lee W. -S¹,Choi Y. -J.¹,Yoo W. -H.¹

Affiliation:

1. Division of Rheumatology; Department of Internal Medicine; Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute of Chonbuk National University Hospital; Jeonju South Korea

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.13736/fullpdf

Reference9 articles.

1. Diagnosis and treatment of pyoderma gangrenosum;Brooklyn;BMJ,2006

2. Etiology and management of pyoderma gangrenosum: a comprehensive review;Ahronowitz;Am J Clin Dermatol,2012

3. Effective strategies for the management of pyoderma gangrenosum: a comprehensive review;Patel;Acta Derm Venereol,2015

4. Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases;Perez-Alvarez;Semin Arthritis Rheum,2011

5. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions;Bennett;Medicine (Baltimore),2000

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibodies in the Management of Inflammation in Wound Healing: An Updated Literature Review;Journal of Clinical Medicine;2024-07-12

2. Treatment Strategies in Neutrophilic Dermatoses: A Comprehensive Review;International Journal of Molecular Sciences;2023-10-26

3. What can inherited immunodeficiencies reveal about pyoderma gangrenosum?;Experimental Dermatology;2023-10-17

4. Refractory pyoderma gangrenosum associated with rheumatoid arthritis successfully treated with upadacitinib. Comments on: “JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum”;International Journal of Dermatology;2023-07-10

5. Multiple Lesions at Different Stages of Pyoderma Gangrenosum in a Crohn’s Disease Patient;Clinical, Cosmetic and Investigational Dermatology;2022-08